While it is true that the SCCS and the ECHA do not meet the same requirements, it is nevertheless extremely disturbing that the SCCS declare homosalate safe up to 0.5% on the basis of an analysis of existing data and that the ECHA call for additional animal tests (subchronic, reprotox)... https://lnkd.in/exX9fyXV Given the existing animal data on this product for the endpoints of interest to ECHA, it's the opportunity to have an evidence-based approach by generating complementary data with NAMs and not animals. To this end, the European Commission could set up an ad hoc working group including ECHA toxicologists to propose a strategy for in silico/in vitro tests to be carried out to answer ECHA's specific questions. In my opinion, the best way to make concrete progress on integrating NAMs into regulatory decisions. #toxicology #nams #echa #sccs #invitro #animaltesting
The Court clarifies the relationship between REACH and Cosmetics Regulations In cases T-655/20 and T-656/20, the General Court has dismissed the actions brought by Symrise against decisions of ECHA’s Board of Appeal (cases A-009-2018 and A-010-2018) which confirmed two ECHA compliance check decisions requesting further information on the properties of the substances homosalate and 2-ethylhexyl salicylate. The judgments clarify that chemical substances that are used as ingredients in cosmetic products may become subject to animal testing under REACH to establish their safety as regards workers’ exposure.
Senior Toxicology and Risk Assessment Manager at Innospec Inc.
10moGreat points Christian. I’m sure Symrise are following a similar train of thinking. Right Kirsten Gerloff?